NSI-189 Phosphate

DRUG2 trials

Sponsors

Neuralstem Inc.

Conditions

Depression

Phase 1

Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189

CompletedNCT01310881

Neuralstem Inc.Depression

Start: 2011-02-28End: 2011-11-30Updated: 2011-11-21

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

CompletedNCT01520649

Neuralstem Inc.Depression

Start: 2012-05-31End: 2014-02-28Updated: 2014-04-02